Martin (Marty) Makary, MD, MPH is a gastro-intestinal/pancreas surgeon and public policy researcher at Johns Hopkins University. He is a prolific author, writing for The Washington Post and The Wall Street Journal, authoring of three New York Times bestselling books – Unaccountable, The Price We Pay and Blind Spots – and regularly commentating on CNN and Fox News. Dr. […]
Read more
With President Donald Trump retaking the White House and Republicans narrowly controlling both the House and Senate, healthcare marketers and publishers must prepare for anticipated legislative, regulatory, and procurement shifts. The CHC and 4A’s Government Relations team in partnership with advocacy experts brings you resources and guidance on what to expect and how to prepare. […]
Read more
The proposed American Privacy Rights Act (APRA) has taken its first step U.S. House legislative process with several issue disagreements becoming more evident. On May 23, the U.S. House Committee on Energy and Commerce Subcommittee on Data, Innovation and Commerce approved the updated APRA, advancing the bill to full committee consideration. Just prior to the […]
Read more
The Consumer Financial Protection Bureau (CFPB) has proposed a rule to define a market for general-use digital consumer payment applications. Larger participants in this market would be subject to CFPB supervision and examination authority under the Consumer Financial Protection Act (CFPA). The proposed market would cover providers of funds transfer and wallet functions through consumer […]
Read more
Through government contracts, advertising agencies can help state, local, and federal governments communicate their mission and important messages to the general public to inspire behavioral change, accelerate adoption of vital programs, and contribute to the greater good. To help agencies navigate the perceived complexities of the government contracting process, the 4A’s Government Relations team has […]
Read more Aug. 30, 2022 – When members of the House and Senate return to Washington Sept. 6 following the Labor Day holiday, they face competing priorities and tight timeframes to take action on the federal budget and user fees, which expire on Sept. 30. Failure to pass the fiscal year 2023 (FY 2023) budget and reauthorize […]
Read more
May 2, 2022 – Although Medicare Advantage (MA) plans often are touted for delivering more benefits at a lower cost than traditional Medicare, some critics argue that MA organizations (MAOs) deny beneficiaries coverage that they would receive under Medicare rules – including MRIs and post-acute care – in order to increase profits. As MA plan […]
Read more
April 4, 2022 – The fiscal year (FY) 2023 budget proposed by President Joe Biden last week emphasizes fiscal restraint more than new, big spending programs, but it does ask for increased funding for pandemic preparedness, the Food and Drug Administration (FDA), and projects such as the Cancer Moonshot and the Advanced Research Projects Agency […]
Read more
Feb. 15, 2022 – Dr. Robert Califf was confirmed to be the next Commissioner of Food and Drugs in a close 50-46 Senate vote today. In a sign of the times, during the 2016 vote for Califf’s first stint as FDA Commissioner, he was confirmed 89-4. “We expect Califf to be a strong leader for […]
Read more